NIH looks for pediatric biomarker proposals

It has been estimated that 70% of the medicines given to children have only been tested in adults. The same is true when it comes to biomarkers. So, the NIH has opened up a new funding program aimed at taking biomarkers that may be effective in adults and developing them further for children. The NIH is accepting proposals for biomarkers developed in adults for use in pediatric diagnosis, prognosis and estimation of disease progression, toxicity and response to therapies. Story

Suggested Articles

Takeda tapped Roche’s Foundation Medicine to develop tissue- and blood-based companion diagnostic tests for its portfolio of lung cancer therapies.

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.